Status:
COMPLETED
Studies of In Vitro B Lymphocyte Responses in Subjects Receiving Tetanus Toxoid Booster Immunization
Lead Sponsor:
National Institute of Allergy and Infectious Diseases (NIAID)
Conditions:
Healthy
Eligibility:
All Genders
Brief Summary
One of the major interests of this laboratory is the characterization of the cellular subpopulations involved in the triggering and immunoregulation of B lymphocytes to produce antibodies. We are asse...
Detailed Description
One of the major interests of this laboratory is the characterization of the cellular subpopulations involved in the triggering and immunoregulation of B lymphocytes to produce antibodies. We are asse...
Eligibility Criteria
Male and female patients 18 years and older.
Patients admitted to the Clinical Center under other approved research protocols designed to investigate immune mediated or inflammatory diseases and who have not been immunized to tetanus toxoid within 6 months.
No pregnant women.
Key Trial Info
Start Date :
June 1 1980
Trial Type :
OBSERVATIONAL
End Date :
June 1 2000
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT00001173
Start Date
June 1 1980
End Date
June 1 2000
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Institute of Allergy and Infectious Diseases (NIAID)
Bethesda, Maryland, United States, 20892